Rafunrafun,
You are invested in Amarin Corp., not REDUCE-IT. Amarin Corp. = Vascepa. Therefore you own Vascepa in small part. How secure are you in Vascepa, given that the FDA may not expand the label for its use, and one can purchase the API very easily, and generic companies are currently pursuing the right to sell knock-off Vascepa, and the FDA has by omission called ethyl ester EPA a dietary ingredient?
That’s the question AMRN bulls need to consider to construct a risk/reward model and allocate capital long, short, or not at all, hopefully with some assistance from a registered investment advisor who can help you and others understand the risk involved (and potential hedging techniques). It’s easy to get in over ones head in the stock market, taking completely unacceptable risks and hurting loved ones as a result. Luck is nice while it’s here, but luck always runs out.
Consider carefully. It’s not just (collectively) you and you being right/wrong here. Lives have been ruined and families torn apart due to not respecting risk, which is often just the result of honest delusion. We’ve all been overcome by belief of one kind or another and subsequently behaved irrationally. Now’s the time to reconsider your beliefs in AMRN, while the stock is trading around highs and the account is flush and before the two catalysts that could result in bankruptcy for AMRN (and apparently a number of its holders) come upon you. Because you absolutely may be wrong.
